摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Benzylthio-1-methyl-4(3H)-quinazolinone

中文名称
——
中文别名
——
英文名称
2-Benzylthio-1-methyl-4(3H)-quinazolinone
英文别名
2-benzylsulfanyl-1-methylquinazolin-4-one
2-Benzylthio-1-methyl-4(3H)-quinazolinone化学式
CAS
——
化学式
C16H14N2OS
mdl
——
分子量
282.4
InChiKey
JWZYDWAUFAWPHJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    58
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • [EN] INHIBITORS OF HISTONE DEACETYLASE<br/>[FR] INHIBITEURS D'HISTONE DÉSACÉTYLASE
    申请人:RODIN THERAPEUTICS INC
    公开号:WO2015200619A1
    公开(公告)日:2015-12-30
    This invention provides compounds that are inhibitors of HDAC2. The compounds (e.g., compounds according to Formula (I), (II), (IIa), (III), (IV), (V), or (VI)) accordingly are useful for treating, alleviating, or preventing a condition in a subject such as a neurological disorder, memory or cognitive function disorder or impairment, extinction learning disorder, fungal disease or infection, inflammatory disease, hematological disease, or neoplastic disease, or for improving memory or treating, alleviating, or preventing memory loss or impairment.
    这项发明提供了抑制HDAC2的化合物。这些化合物(例如,符合式(I)、(II)、(IIa)、(III)、(IV)、(V)或(VI)的化合物)可用于治疗、缓解或预防受试者的疾病,如神经系统疾病、记忆或认知功能障碍或损伤、消退学习障碍、真菌疾病或感染、炎症性疾病、血液疾病或肿瘤性疾病,或用于改善记忆或治疗、缓解或预防记忆丧失或损伤。
  • INHIBITORS OF HISTONE DEACETYLASE
    申请人:Rodin Therapeutics, Inc.
    公开号:US20170204070A1
    公开(公告)日:2017-07-20
    This invention provides compounds that are inhibitors of HDAC2. The compounds (e.g., compounds according to Formula (I), (II), (IIa), (III), (IV), (V), or (VI)) accordingly are useful for treating, alleviating, or preventing a condition in a subject such as a neurological disorder, memory or cognitive function disorder or impairment, extinction learning disorder, fungal disease or infection, inflammatory disease, hematological disease, or neoplastic disease, or for improving memory or treating, alleviating, or preventing memory loss or impairment.
  • US9981920B2
    申请人:——
    公开号:US9981920B2
    公开(公告)日:2018-05-29
查看更多